Zijun Lu is a third-year PhD student at Monash University, specialising in lymphatic drug delivery, lipid-based formulation, and acute critical illness. Zijun’s work aims to improve therapeutic strategies and patient outcomes in critical care settings.

Yuqing Miao received his PhD degree from the Northwest University in 2021. Following this, he began working at Shaanxi University of Chinese Medicine. His current research interests focus on the design and synthesis of magnetic and metal-polyphenol nanomaterials for bioimaging and therapy of diseases.

Dr Joanna Harnett holds a Bachelor and Master of Health Science (Complementary Medicine) and PhD (nutritional pharmacology). Joanna is a senior lecturer (complementary medicines) within the Faculty of Medicine Health at the University of Sydney’s Pharmacy School. Her teaching and research activity include: the appropriate and safe use of complementary medicine products including drug-herb interactions, integrative medicine education and communication, and gastrointestinal health and the microbiome. Joanna supervises higher degree research students in these three areas. She currently serves on the board of the International Society for Traditional, Complementary, Integrative Medicine Research and a member of the Australian TGA Advisory Committee for Complementary Medicines.

Dr. Zhu obtained his PhD degree in pharmacology from Peking Union Medical College in 2008, and then took postdoctoral training in Nanyang Technological University and the Chinese University of Hong Kong. In 2014, he joined Macau University of Science and Technology. His current research interests include drug discovery targeting protein degradation and design of novel drug delivery systems for natural products, especially focusing on the synergistic pharmacological activities of the nanocarriers. In 2017, he got the CNPHARS-Servier Prize for Young Investigators in Pharmacology in China.

Ethan is a third-year PhD student in the Drug Delivery, Disposition and Dynamics theme at the Monash Institute of Pharmaceutical Sciences. He initially trained and registered as a clinical pharmacist and is currently undertaking his graduate research studies in the Nicolazzo Lab focusing on drug transporters and how they may be impacted by factors related to Alzheimer's disease.

Dr. Jin-Jian Lu is an Associate Professor in University of Macau and received his Ph.D. degree in Shanghai Institute of Meteria Medica, Chinese Academy of Sciences in 2009. Currently, Dr. Lu is mainly engaged in the discovery and mechanism study of anti-cancer compounds based on tumor microenvironment. He is also interested in studying the new targets and strategies for cancer therapy. He has been the recipient of more than 10 research grants funded by National Science Foundation of China, Science and Technology Development Fund Macao S.A.R and so on. Dr. Lu has published more than 200 scientific papers in the SCI journals including J Hematol Oncol, Acta Pharm Sin B and Pharmacol Ther (Total citations 10000+, H-index 54, Scopus). He is the editorial or youth editorial board member for 11 professional journals including Transl Oncol and Chin J Nat Med, and the referee for 100+ peer-reviewed journals. He was awarded as the 2nd Prize of Natural Science: Macao Science and Technology Awards (twice) and CNPHARS Annual Young Pharmacologists. (2/8/2024)